Ovitex 2s
Payments companies reported to CMS as associated with Ovitex 2s. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ovitex 2s, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ovitex 2s
These are the largest totals companies reported as associated with Ovitex 2s. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Paul Szotek | Indianapolis, IN | Surgery | $361,650.58 |
| Jorge Florin | Winter Garden, FL | Surgery | $234,237.08 |
| Samir Awad | Houston, TX | Surgical Critical Care | $82,505.59 |
| Salvatore Pacella | San Diego, CA | Plastic Surgery | $76,447.86 |
| Ian Valerio | Columbus, OH | Plastic Surgery | $68,494.97 |
| Howard Langstein | Rochester, NY | Plastic and Reconstructive Surgery | $68,097.08 |
| Evan Katzel | Philadelphia, PA | Plastic Surgery | $66,139.58 |
| Rahm Nazerali | Palo Alto, CA | Plastic Surgery | $65,526.23 |
| George Denoto | Manhasset, NY | Surgery | $47,435.93 |
| Neilendu Kundu | Cleveland, OH | Surgery | $41,637.62 |
Prescribed Ovitex 2s?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.